Edition:
United Kingdom

Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329.SS)

600329.SS on Shanghai Stock Exchange

16.02CNY
6:59am GMT
Change (% chg)

¥0.23 (+1.46%)
Prev Close
¥15.79
Open
¥15.78
Day's High
¥16.09
Day's Low
¥15.77
Volume
1,775,938
Avg. Vol
2,741,715
52-wk High
¥19.98
52-wk Low
¥15.70

Latest Key Developments (Source: Significant Developments)

Tianjin Zhongxin Pharmaceutical says qtrly ‍revenue was down 14​ percent
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>::Qtrly ‍revenue RMB1.31 billion, down 14​ percent.Qtrly profit, net of tax attributable RMB82 million versus RMB91.6 mln‍​.  Full Article

Tianjin Zhongxin Pharmaceutical Group appoints Li Li Qun as chairman​
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>:‍Resolution passed to appoint Li Li Qun as chairman​.  Full Article

Tianjin Zhongxin Pharmaceutical Group to pay 1 yuan per 10 shares as H1 2016 div
Monday, 15 Aug 2016 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>:Says it to pay a cash dividend of 1 yuan (before tax) for every 10 shares to shareholders for H1 of 2016.  Full Article

Tianjin Zhongxin Pharmaceutical Group to pay 2015 div on July 15
Friday, 8 Jul 2016 

Tianjin Zhongxin Pharmaceutical Group <600329.SS> Corp Ltd: Says it will pay cash dividend of 1.5 yuan per 10 shares (before tax) to shareholders for 2015 as a record of July 14 .Says the company's shares will be traded ex-right and ex-dividend on July 15 and the dividend will be paid on July 15.  Full Article

Tianjin Zhongxin Pharmaceutical Group Corp Ltd updates on recall of a product from Hong Kong - Reuters News
Tuesday, 26 Apr 2016 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:Tianjin zhong xin pharm group (update on recall of a product from Hong Kong).Tianjin market supervision committee has inspected the Long Shun Rong pharmaceutical factory.Says pursuant to recall 314 boxes have been recalled as at 24 April 2016.Company has procured the LSR factory to cease its production, recall the product from Hong Kong.Tianjin market supervision committee requested that the LSR factory cease production until any problems are rectified.Company has not received any notice about the commencement of investigations on the LSR factory.Will be sending its staff to Hong Kong to supervise Ming Hua Company in recall and destruction of product.Co suspended exports of all the Chinese medicine produced in the LSR factory to Hong Kong.  Full Article

Tianjin Zhongxin Pharmaceutical Group says 2015 dividend payment as 0.15 yuan per share
Wednesday, 30 Mar 2016 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:To pay cash dividend of 1.5 yuan per 10 shares (before tax) to the company's shareholders for 2015.  Full Article

Tianjin Zhongxin Pharmaceutical Group subsidiary receives GMP certificate
Saturday, 19 Mar 2016 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:Says Tianjin-based pharmaceutical subsidiary received goods manufacture practice (GMP) certificate from Tianjin Market and Quality Supervision Administration.Certificate issued to imported drugs packaging (cephalosporin powder injection) and the valid period is until March 10, 2021.  Full Article